top of page
shutterstock_1300153159.jpg

2024 Webcasts

Friday, June 21, 2024

Aline Charabaty, MD, AGAF, FACG

Tracking Disease Activity and Treatment Response in IBD: Biomarkers and Wearables

Bruce E. Sands, MD, MS

Will Someone Define What Is Moderate to Severe Disease?

Russell D. Cohen, MD, FACG, AGAF

Playing JAKs: Right Patient, Right Time, Right Dose

Ryan Stidham, MD, MSc

Will AI Change Our Approach to Mucosal Healing?

Stephen B. Hanauer, MD

How "I" Select First-Line Advanced Therapies for Moderate-Severe Ulcerative Colitis

Maria T. Abreu, MD

Combining Therapies for IBD: Rationale and Practical Aspects

Rishika Chugh, MD

Current & Future Utility of Intestinal Ultrasound for Disease Monitoring

Sara N. Horst, MD, MPH

Selecting First Line Advanced Therapy in Crohn's Disease

Saturday, June 21, 2024

Anthony Lembo, MD

FDA Endpoints in Gastroparesis

Darren M. Brenner, MD, AGAF, FACG, RFF

When It's Not...The IBS-D Mimickers

Colleen R. Kelly, MD, FACG, AGAF

Update on C. difficile

Baharak Moshiree, MD

Novel Capsule Technologies for DGBI and Motility Disorders

Evan S. Dellon, MD, MPH

Eosinophilic GI Diseases

Mark Pimentel, MD

Microbiome-Based Therapies?

Satish Rao, MD, PhD

Novel Breath Testing Technologies

William D. Chey, MD, FACG

Management of Helicobacter pylori in North America

Lin Chang, MD

Updates on Treatment of IBS-C and CIC

bottom of page